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Abstract  
Background: While rates of postpartum haemorrhage (PPH) have continued to rise, it is not clear if 
the association with other morbidity and transfusion has changed over time. This study explores the 
recent trend in postpartum haemorrhage and risk factors for transfusion and other severe adverse 
maternal outcomes following postpartum haemorrhage, stratified by mode of delivery.  
Methods: Linked birth and hospital data were used to examine ICD-10AM coded PPH and outcomes 
in maternal birth admission records,  2003-2011 in hospitals in New South Wales (NSW), Australia 
(N= 818,965 singleton pregnancies). Trends were calculated on the whole population, and among 
subgroups, and tested using the Cochran Armitage test for trend. Logistic regression models were 
developed separately for vaginal and caesarean births, and for a maternal morbidity composite 
indicator (excluding transfusion) and red cell transfusion.  Adjusted odds ratios (aOR) for yearly 
change and 95% confidence intervals (CI) are presented. Adjustment included maternal (eg. age, 
country of birth) and pregnancy factors (eg. parity, interventions, pregnancy complications).  
Results:  Overall, there was a significant increase in the PPH rate, from 6.1% in 2003 to 8.3% in 2011 
(p<0.0001). Having accounted for maternal and pregnancy factors, there was no significant increase 
in morbidity among women delivering vaginally with a PPH (aOR for yearly change 0.97 (0.94-1.00); 
p=0.36), and a slight decrease among women delivered by caesarean section (aOR 0.96 (0.92-0.99); 
p<0.01). There was a slight increase in transfusions for vaginal births (aOR 1.02 (1.00-1.03); p<0.01), 
however there was no significant trend amongst caesarean births (aOR 0.99 (0.97-1.01); p=0.30).  
Conclusions: PPH has become more frequent, however this has not been associated with increased 
maternal morbidity. This suggests that the increase in PPH may represent fewer severe haemorrhages, 
well-managed haemorrhage or better recording of PPH. 
 
Keywords:  maternal morbidity; postpartum haemorrhage; transfusion;  
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Background 
Postpartum haemorrhage rates have increased in the developed world[1]. At the same time, 
transfusion rates associated with childbirth have risen in Australia[2], Canada[3] and the United 
States[4]. It is unclear whether the increased rates of postpartum haemorrhage represent more severe 
haemorrhage. In Australia, the postpartum haemorrhage rate increased by around 25% from 1994 to 
2002. During this period, the transfusion rate among women with postpartum haemorrhage increased 
by 500% (from 2% to 12%).[5]. Obstetric transfusions (not limited to women with postpartum 
haemorrhage) increased from 1.2% of births in 2001 to 1.6% of births in 2010[2].  
Current population-based pregnancy and birth data do not include details of the amount of blood lost 
at postpartum haemorrhage, nor the quantity of blood transfused. In the absence of these details, post-
haemorrhage outcomes such as maternal morbidity and transfusion may provide insight into whether 
bleeding is becoming more severe over time. Given increasing caesarean section rates and different 
risk factors reportedly associated with vaginal and caesarean births[6,7], it is worthwhile considering 
the outcomes following postpartum haemorrhage separately for these birth modes. 
The aims of this study were to determine the recent trend in postpartum haemorrhage, rates of 
associated maternal morbidity and transfusion, and risk factors for adverse maternal outcomes 
following postpartum haemorrhage stratified by mode of delivery. 
Methods 
The study population consisted of all women with livebirths or stillborn infants of at least 20 weeks 
gestation in NSW hospitals between 2003 and 2011. Data on maternal demographics, the pregnancy, 
labour and birth were obtained from the Perinatal Data Collection (‘Birth data’). This is a legislated 
statewide record of all births in NSW, and is completed by the midwife or doctor at the time of birth. 
Data on maternal diagnoses and procedures were obtained from the Admitted Patients Data Collection 
(‘Hospital data’), which contains data collected on all private and public hospital discharges in NSW. 
Diagnoses and procedures associated with each hospital discharges are coded according to the 10
th
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revision of the International Classification of Diseases, Australian Modification (ICD10-AM)[8] and 
the Australian Classification of Health Interventions (ACHI)[9] respectively. 
The Centre for Health Record Linkage performed probabilistic linkage of the hospital and birth data, 
to assign unique project identifiers to each mother, allowing both longitudinal linkage (of 
pregnancies), and linkage of hospitalisations during and following pregnancy. For this study, rates of 
missed and incorrect links were less than 0.5%. 
Postpartum haemorrhage was identified from the hospital data using ICD codes (O72). Blood loss of 
equal or greater than 500mL following a vaginal birth, or equal or greater than 750mL following a 
caesarean birth is classified as a postpartum haemorrhage [10]. Validation studies have indicated that 
postpartum haemorrhage is accurately reported, although under-enumerated with sensitivity and 
specificity of 73.8% and 98.9%, respectively.[11] Previous postpartum haemorrhage was defined as a 
postpartum haemorrhage reported in any previous pregnancy (since July 2001) and was obtained from 
the longitudinal linkage of a woman’s pregnancies.  
Outcomes of interest were severe maternal morbidity and blood transfusion. Maternal morbidity was 
measured using a validated composite indicator of adverse outcomes.[12] This indicator includes 
diagnoses such as shock, uterine rupture, and cerebrovascular accident as well as procedures including 
assisted ventilation, dialysis, evacuation of haematoma, hysterectomy, dilatation and curettage under 
general anaesthesia, and embolisation or ligation of blood vessels. The original indicator included 
blood transfusion as a component of morbidity, however this was excluded from the criteria for 
morbidity for this study. Use of a composite indicator overcomes the under-ascertainment of 
individual diagnoses and procedures.[13] Blood transfusion was defined in this study as transfusion of 
whole blood or red blood cells (ACHI 13706-01, 13706-02)[9], which is well reported (sensitivity and 
specificity of 83.1% and 99.9%, respectively).[11] Since we were interested in trends in transfusion 
and morbidity, women experiencing both a transfusion and a morbidity diagnosis were included in 
both the transfusion and morbidity outcomes. A sensitivity analysis was performed to assess whether 
estimates changed when transfusion and morbidity were treated as mutually exclusive outcomes. 
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Maternal demographics, pregnancy, labour and delivery data were obtained from the birth data; 
chronic conditions (chronic hypertension, diabetes, renal and cardiac conditions), antepartum 
haemorrhage (APH), morbidly adherent placenta, and placenta praevia were obtained from the 
hospital data; and pregnancy hypertension and gestational diabetes were obtained from either birth or 
hospital data based on validation studies indicating the most reliably reported sources. [11,14-17] 
Trends were calculated on the whole population, and among subgroups, and tested using the Cochran 
Armitage test for trend. Logistic regression models were developed to assess the change in severity of 
postpartum haemorrhage over time among birth admissions for women delivering a singleton infant. 
Models were developed separately for vaginal and caesarean births, and for maternal morbidity and 
transfusion. Factors which were significant in a univariate model at alpha 0.3 were entered into the 
initial multivariable model, and progressively removed until only factors significant at alpha 0.05 
remained. Year and maternal age were retained in all models, and variables considered confounders if 
estimates changed more than 10% on their removal. A sensitivity analysis was also performed 
including diagnosis codes for placenta praevia with haemorrhage as part of the definition of a 
postpartum haemorrhage, however associations were unchanged so this analysis has not been 
included. All analysis was conducted in SAS 9.3. Ethics approval was from the NSW Population and 
Health Services Research Ethics Committee. 
Results 
Between 2003 and 2011 there were 818,965 births in New South Wales. Overall, a postpartum 
haemorrhage was reported in 59,639 (7.3%) of births. There was a significant increase in the 
postpartum haemorrhage rate, from 6.1% (n=5158) in 2003 to 8.3% (n=7886) in 2011 (p<0.0001). 
Among caesarean births, the rate of postpartum haemorrhage increased by 55% (3.7% to 5.7%), 
whereas among vaginal births they increased by 36% (7.0% to 9.5%) (Figure 1 and 2). Women with a 
postpartum haemorrhage were more likely to have multifetal pregnancies, be primiparous, have 
pregnancy hypertension, antepartum haemorrhage, instrumental delivery and large-for-gestational age 
infants, and were less likely to be a private patient. Women with a previous postpartum haemorrhage 
6 
 
were more likely to have a postpartum haemorrhage in the current pregnancy than women without a 
history of postpartum haemorrhage (Table 1). 
Subsequent morbidity among women with a postpartum haemorrhage 
 
There was no significant change in the crude maternal morbidity rate (excluding transfusion) among 
women with a postpartum haemorrhage (p=0.28) (2.9 per 100 births to 2.8 per 100 births). Having 
accounted for maternal and pregnancy factors, there was no significant increase in morbidity among 
women with a PPH delivering vaginally (aOR for yearly change 0.97 (0.94-1.00); p=0.36), and a 
slight decrease among women delivering by caesarean section (aOR 0.96 (0.92-0.99); p<0.01) (Table 
2).   
Risk factors for maternal morbidity among women were similar for those giving birth vaginally and 
by caesarean section. These risk factors included advanced maternal age (>35 years), women with 
chronic conditions, maternal birth outside Australia, preterm birth, placenta praevia, morbidly 
adherent placenta, pregnancy hypertension, and women with a history of postpartum haemorrhage. 
Instrumental deliveries were associated with higher morbidity among vaginal births (Table 2).   
Transfusion among women with a postpartum haemorrhage 
There was a significant increase in the red cell transfusion rate (p<0.001) among women with a 
postpartum haemorrhage from 12.3 per 100 births in 2003 to 14.5 per 100 births in 2011. After 
adjustment for other risk factors, there was a significant increase in transfusions for vaginal births 
(aOR 1.02 (1.00-1.03); p<0.01), however there was no significant trend amongst caesarean births 
(aOR 0.99 (0.97-1.01);  p=0.30) (Table 3). Risk factors for blood transfusion following postpartum 
haemorrhage included the extremes of maternal age, preterm birth, morbidly adherent placenta, 
placenta praevia, antepartum haemorrhage, induction of labour, previous postpartum haemorrhage, 
and delivery in a regional hospital. For vaginal deliveries, instrumental births, pregnancy 
hypertension, smoking and previous caesarean section were also risk factors. For caesarean births, 
higher parity was associated with increased risk of transfusion (Table 3) 
7 
 
A sensitivity analysis (data not shown) was performed in which women experiencing both a 
transfusion and morbidity (n=925) were only included in the morbidity outcome. The increase in 
blood transfusion persisted but was slightly attenuated (10.7 to 12.7; p<0.001). The adjusted 
morbidity and transfusion trends were unchanged. 
Discussion 
This population-based study indicates that while the postpartum haemorrhage rate has continued to 
rise, there has been no increase in maternal morbidity. However, the rate of transfusion associated 
with haemorrhage has increased slightly over the study period. We found not only had postpartum 
haemorrhage rates increased between 2003 and 2011, but that the increase over this 9 year period was 
proportionally higher than previously reported [18](36% increase compared to 25% in the previous 8 
year period). Although the population burden of postpartum haemorrhage is among vaginal births, the 
increase in the postpartum haemorrhage rate was primarily driven by haemorrhage post-caesarean 
birth.  
 
Despite known under-ascertainment of postpartum haemorrhage for women delivered by caesarean 
section,[19] there are no known reporting changes over the study period. Other studies reporting 
increases in overall postpartum haemorrhage have not stratified by mode of delivery so it is unknown 
whether this trend is mirrored in other settings.[1,20] A recent Canadian paper suggested that post-
caesarean atonic haemorrhages increased by 95% from 2001 to 2009 while post-vaginal delivery 
atonic haemorrhages increased by 35%.[3] It is possible that bleeding post-caesarean that would 
previously not been classified as postpartum haemorrhage (vaginal/ vulvular haematomas, uterine 
cavity bleeding post-closure or bleeding masked by drapes or dressings) may be being incorporated 
into more recent measures of postpartum haemorrhage. We have previously demonstrated 
misclassification of reporting on PPH cause using ICD reporting, in particular over-estimation of the 
contribution of uterine atony to PPH.[21] There are no known practice changes associated with 
caesarean delivery over this period that explain increased haemorrhage rates. 
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Reassuringly, morbidity rates post-haemorrhage do not appear to have increased, and among 
caesarean deliveries decreased over the study period. This suggests that the increase in postpartum 
haemorrhage does not represent an increase in severe haemorrhage resulting in life-threatening 
complications. While more postpartum haemorrhages have been identified, the management of these 
may be preventing deterioration into severe morbidity. Previously, postpartum haemorrhage was 
reported to be driving up rates of maternal morbidity in Australia[13]; importantly, this previous study 
included transfusion as part of the composite measure of maternal morbidity, whereas for the current 
study we have investigated transfusion separately. 
 
After adjustment for other risk factors, there was a significant increase in red cell transfusions for 
vaginal births, however there was no significant trend among caesarean births. Given that the increase 
among vaginal births occurred in the context of no increase in morbidity, this may reflect an increased 
frequency of use of red cell transfusion for less severe cases of haemorrhage post-vaginal delivery. 
The proportion of women with postpartum haemorrhage receiving transfusion had previously 
increased dramatically (from 2% in 1994 to 12% in 2002).[5] Our study suggests that a higher 
proportion of women are now transfused (12% in 2003 to 15% in 2011), however, the rate of increase 
is much less than previously demonstrated. Without details on actual blood loss or timing of 
transfusion (immediately post-delivery or a few days postpartum) it is difficult to speculate about the 
severity of haemorrhages being transfused. Nevertheless, in the setting of increased obstetric 
transfusions[2] and the largely unpredictable nature of postpartum haemorrhage, patient blood 
management strategies including recognizing and treating antepartum anemia, active management of 
the third stage of labour and use of iron therapy in the setting of postpartum anemia are worthwhile 
considering for pregnant and recently pregnant women. 
 
While preterm birth and the presence of chronic conditions increased the risk of morbidity following 
postpartum haemorrhage, even when these factors were taken into account, women with a previous 
caesarean birth or previous birth complicated by postpartum haemorrhage remained at increased risk 
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of subsequent morbidity. The role previous birth complications play in index birth complications is 
increasingly being recognised[22,23] and underlines the importance of recording and taking into 
account obstetric history when caring for multiparous women.  
 
Strengths of this study include the use of validated population-based data to investigate rare outcomes 
including severe adverse maternal outcomes and transfusion as well as the incorporation of previous 
obstetric history. Using record linkage we have been able to take into account previous postpartum 
haemorrhage and previous caesarean, although for the earlier years of the study only a two year 
lookback period was available. The two outcomes considered in this study may be inter-related –a 
transfusion in some cases is likely to prevent further morbidity.  
Conclusions 
While women giving birth today are more likely to have a postpartum haemorrhage, on the whole 
they are no more likely to experience adverse outcomes subsequent to the haemorrhage than in 2003. 
The increase in post-caesarean haemorrhage highlights the need for vigilance in the operative setting. 
The marginal increase in red cell transfusions following vaginal birth postpartum haemorrhage 
warrants further investigation. The increase in PPH may represent fewer severe haemorrhages, well-
managed haemorrhage or better recording of PPH; the increase in transfusions following postpartum 
haemorrhage may indicate changes in management of third stage of labour. Further insight into the 
severity of postpartum haemorrhages in the Australian setting will soon be available via record 
linkage that allows number of units transfused to each woman to be assessed. 
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Table 1 Maternal and pregnancy characteristics of women with and without postpartum haemorrhage 
(PPH), NSW, 2003-2011 
Variable PPH 
(N=59,639) 
No PPH 
(N=759,326) 
Maternal age     
   Under 20 2386 ( 4.0) 27407 ( 3.6) 
   20-34 45012 ( 75.5) 562067 ( 74.0) 
   35+ 12241 ( 20.5) 169852 ( 22.4) 
Smoker 6524 ( 10.9) 88992 ( 11.7) 
Australian born 38530 ( 64.6) 523266 ( 68.9) 
Multiple birth 1647 ( 2.8) 10927 ( 1.4) 
Parity     
   1st 29179 ( 48.9) 317620 ( 41.8) 
   2nd-4th 28021 ( 47.0) 412846 ( 54.4) 
   5+ 2366 ( 4.0) 27588 ( 3.6) 
Previous Caesarean 5489 ( 9.2) 111610 ( 14.7) 
Gestational diabetes 3842 ( 6.4) 45688 ( 6.0) 
Pregnancy hypertension 6740 ( 11.3) 69387 ( 9.1) 
Antepartum haemorrhage 2440 ( 4.1) 19246 ( 2.5) 
Malpresentation 2037 ( 3.4) 35981 ( 4.7) 
Previous PPH 10823 ( 18.1) 27116 ( 3.6) 
Placenta praevia 1253 ( 2.1) 7678 ( 1.0) 
Morbidly adherent placenta 1163 ( 2.0) 826 ( 0.1) 
Gestational age     
   20-32 weeks 1372 ( 2.3) 11654 ( 1.5) 
   33-36 weeks 3023 ( 5.1) 37969 ( 5.0) 
   37+ weeks 55244 ( 92.6) 709703 ( 93.5) 
Mode of birth     
  Normal vaginal delivery 36717 ( 61.6) 451652 ( 59.5) 
  Caesarean 11860 ( 19.9) 228010 ( 30.0) 
    Caesarean without labour 5465 ( 9.2) 133292 ( 17.6) 
    Caesarean with labour 6393 ( 10.7) 94704 ( 12.5) 
  Instrumental delivery 11186 ( 18.8) 80382 ( 10.6) 
  Forceps 4802 ( 8.1) 26272 ( 3.5) 
  Vacuum 6384 ( 10.7) 54110 ( 7.1) 
Induction 20479 ( 34.3) 202866 ( 26.7) 
Large for gestational age 9197 ( 15.4) 78804 ( 10.4) 
Hospital type     
  Tertiary 31503 ( 52.8) 307664 ( 40.5) 
   Regional 11561 ( 19.4) 161522 ( 21.3) 
   Urban/other 8754 ( 14.7) 99859 ( 13.2) 
   Private 7821 ( 13.1) 190281 ( 25.1) 
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Table 2 Risk factors for maternal morbidity among women with a postpartum haemorrhage, NSW, 2003-2011. 
    Vaginal births N=46955 Caesarean births N=11037 
    Univariate Multivariate Univariate Multivariate 
  
  Odds ratio 95% CI P Odds 
Ratio 
95% CI Odds 
ratio 
95% CI P Odds 
ratio 
95% CI 
Maternal Age                      
  Under 20 1.01 ( 0.72, 1.42)   1.10 ( 0.78, 1.56) 0.27 ( 0.10, 0.72)   0.38 ( 0.14, 1.04) 
  20-34  Ref         Ref           
  35+ 1.42 ( 1.21, 1.67) <0.0001 1.24 ( 1.05, 1.47) 1.45 ( 1.23, 1.70) <0.0001 1.20 ( 1.00, 1.42) 
Private patient  0.92 ( 0.78, 1.09) 0.33 .   1.12 ( 0.93, 1.35) 0.22 .   
Smoker  1.04 ( 0.85, 1.30) 0.67 .   1.35 ( 1.09, 1.69) <0.01 .   
Parity                      
  1 Ref           Ref          
  2-4 0.95 ( 0.83, 1.09) 0.42 .   1.93 ( 1.62, 2.29) <0.0001 .   
  5+ 1.18 ( 0.84, 1.64)   .   3.21 ( 2.37, 4.34)   .   
Australian born  0.84 ( 0.73, 0.96) 0.01 0.81 ( 0.70, 0.94) 0.86 ( 0.74, 1.01) 0.07 0.77 ( 0.65, 0.92) 
Gestational Age                      
  20-32 4.36 ( 3.25, 5.84) <0.0001 2.59 ( 1.76, 3.82) 3.63 ( 2.74, 4.80) <0.0001 2.22 ( 1.61, 3.07) 
  33-36    Ref       Ref    
  37+ 1.58 ( 1.16, 2.17)   1.29 ( 0.93, 1.79) 2.84 ( 2.29, 3.52)   1.52 ( 1.17, 1.97) 
Mode of birth                      
  Vaginal    Ref                
  Forceps 1.22 ( 0.98, 1.51) 0.12         .   
  Vacuum 1.14 ( 0.94, 1.39)           .   
  Caesarean in 
labour 
          0.80 ( 0.68, 0.93) <0.01 1.76 ( 1.45, 2.13) 
  Pre-labour 
caesarean 
          Ref         
Induction  1.18 ( 1.03, 1.36) 0.03 .   0.80 ( 0.67, 0.96) 0.02   
Large for 
gestational age   
0.83 ( 0.67, 1.02) 0.07 .   0.73 ( 0.59, 0.90) <0.01 .   
Chronic 
conditions 
3.64 ( 2.63, 5.03) <0.0001 2.90 ( 2.06, 4.08) 2.04 ( 1.47, 2.85) <0.0001 2.08 ( 1.46, 2.96) 
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Pregnancy factors                      
  Antepartum 
haemorrhage 
1.76 ( 1.30, 2.38) <0.0001 .   1.60 ( 1.25, 2.05) <0.0001 .   
  Previous 
caesarean 
1.79 ( 1.38, 2.31) <0.0001 1.62 ( 1.24, 2.13) 2.18 ( 1.86, 2.55) <0.0001 2.00 ( 1.66, 2.40) 
  Previous PPH 1.5 ( 1.28, 1.76) <0.0001 1.41 ( 1.20, 1.65) 2.35 ( 1.99, 2.79) <0.0001 1.75 ( 1.45, 2.12) 
  Malpresentation 4.22 ( 2.88, 6.20) <0.0001 .   1.30 ( 1.05, 1.62) 0.02 .   
  Morbidly adherent 
placenta 
4.96 ( 3.81, 6.47) <0.0001 4.24 ( 3.20, 5.61) 17.45 ( 13.81, 22.05) <0.0001 10.33 ( 7.89, 13.51) 
  Placenta praevia      3.97 ( 3.29, 4.78) <0.0001 2.30 ( 1.79, 2.95) 
  Gestational 
diabetes 
1.22 ( 0.94, 1.59) 0.14 .   1.02 ( 0.78, 1.34) 0.88 .   
  Pregnancy 
hypertension 
1.63 ( 1.35, 1.97) <0.0001 1.66 ( 1.35, 2.04) 1.42 ( 1.16, 1.73) <0.01 1.55 ( 1.24, 1.94) 
Year of birth            
  1 year 
increments 
0.99 ( 0.96, 1.02) 0.40 0.99 ( 0.96, 1.01) 0.97 ( 0.94, 1.00) 0.07 0.96 ( 0.92, 0.99) 
Hospital                 
  Tertiary   Ref           Ref    
  Urban 1.02 ( 0.84, 1.24)   .   0.75 ( 0.58, 0.98)   .   
  Regional 0.98 ( 0.74, 1.17)   .   0.88 ( 0.70, 1.10)   .   
  Private 0.91 ( 0.74, 1.14) 0.81 .   1.03 ( 0.80, 1.30) 0.13 .   
Numbers in bold represent statistically significant adjusted risk or protective factors for maternal morbidity. Chronic conditions included chronic 
hypertension, pre-existing diabetes, renal disease, cardiac disease. 
15 
 
Table 3 Risk factors for red cell blood transfusion among women with a postpartum haemorrhage, NSW, 2003-2011. 
    Vaginal births N=46955 Caesarean births N=11037 
    Univariate Multivariate Univariate Multivariate 
  
  Odds 
ratio 
95% CI P Odds ratio 95% 
CI 
 Odds ratio 95% 
CI 
P Odds 
ratio 
95% 
CI 
 
Maternal Age                       
  Under 20 1.46 ( 1.29, 1.64)   1.26 ( 1.11, 1.43)  1.67 ( 1.25, 2.23)   2.04 ( 1.52, 2.75)  
  20-34 Ref           Ref           
  35+ 1.09 ( 1.01, 1.17) <0.0001 1.14 ( 1.06, 1.23)  1.32 ( 1.19, 1.46) <0.0001 1.08 ( 0.97, 1.21)  
Private patient 0.81 ( 0.76, 0.87) <0.0001 0.88 ( 0.79, 0.97)  1.12 ( 1.00, 1.26) 0.06 .    
Smoker 1.21 ( 1.12, 1.31) <0.0001 1.16 ( 1.07, 1.26)  1.2 ( 1.00, 1.35) 0.05 .    
Parity                      
  1 0.76 ( 0.72, 0.81) <0.0001 0.80 ( 0.74, 0.85)  1.27 ( 1.15, 1.41) <0.0001 1.18 ( 1.05, 1.32)  
  2-4 Ref      Ref   Ref           
  5+ 0.96 ( 0.83, 1.11)   0.85 ( 0.73, 0.99)  2.54 ( 2.07, 3.11)   2.06 ( 1.65, 2.57)  
Australian born 1.03 ( 0.98, 1.09) 0.27 .    0.86 ( 0.78, 0.95) <0.01 0.74 ( 0.66, 0.83)  
Gestational Age                       
  20-32 1.49 ( 1.22, 1.81) <0.0001 1.36 ( 1.08, 1.72)  2.56 ( 2.07, 3.17) <0.0001 1.79 ( 1.40, 2.29)  
  33-36 1.54 ( 1.35, 1.76)   1.45 ( 1.26, 1.66)  1.74 ( 1.48, 2.04)   1.07 ( 0.89, 1.29)  
  37+ Ref           Ref           
Mode of birth                       
  Vaginal Ref                     
  Forceps 1.75 ( 1.61, 1.90) <0.0001 1.69 ( 1.54, 1.84)             
  Vacuum 1.34 ( 1.24, 1.45)   1.31 ( 1.20, 1.43)             
  Caesarean in 
labour 
           0.97 ( 0.88, 1.07) 0.54 .    
  Pre-labour 
caesarean 
           Ref           
Induction 1.18 ( 1.12, 1.25) <0.0001 1.13 ( 1.06, 1.19)  0.87 ( 0.77, 0.97) 0.01 1.25 ( 1.10, 1.42)  
Large for gestational 
age 
1.06 ( 0.98, 1.15) 0.13 .    1.00 ( 0.89, 1.13) 0.98 .    
Chronic conditions 1.46 ( 1.19, 1.80) <0.0001 1.28 ( 1.04, 1.58)  1.18 ( 0.91, 1.52) 0.22 .    
Pregnancy factors                       
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  Antepartum 
haemorrhage 
1.64 ( 1.43, 1.88) <0.0001 1.48 ( 1.28, 1.70)  1.81 ( 1.55, 2.13) <0.0001 1.47 ( 1.24, 1.76)  
  Previous 
caesarean 
1.27 ( 1.12, 1.44) <0.0001 1.41 ( 1.23, 1.60)  1.17 ( 1.05, 1.30) <0.01 .    
  Previous PPH 1.36 ( 1.27, 1.46) <0.0001 1.41 ( 1.32, 1.52)  1.56 ( 1.39, 1.76) <0.0001 1.28 ( 1.13, 1.45)  
  Malpresentation 1.35 ( 1.03, 1.76) 0.03 .    1.17 ( 1.01, 1.34) 0.04 .    
  Morbidly 
adherent placenta 
3.83 ( 3.30, 4.44) <0.0001 .    7.92 ( 6.31, 9.94) <0.0001 5.03 ( 3.94, 6.42)  
  Placenta praevia    .    3.53 ( 3.08, 4.05) <0.0001 2.63 ( 2.25, 3.07)  
  Gestational 
diabetes 
1.05 ( 0.93, 1.18) 0.45 .    0.92 ( 0.77, 1.10) 0.38 .    
  Pregnancy 
hypertension 
1.50 ( 1.38, 1.63) <0.0001 1.37 ( 1.26, 1.49)  1.01 ( 0.88, 1.16) 0.89 .    
Year of birth             
  1 year increments 1.03 ( 1.02, 1.04) <0.0001 1.02 ( 1.01, 1.03)  1.00 ( 0.98, 1.02) 0.83 0.99 ( 0.97, 1.01)  
Hospital             
  Tertiary Ref      Ref      
  Urban 0.95 ( 0.88, 1.03)   1.06 ( 0.97, 1.15)  0.91 ( 0.77, 1.06)   1.02 ( 0.87, 1.20)  
  Regional 1.22 ( 1.14, 1.31)   1.28 ( 1.20, 1.38)  1.25 ( 1.10, 1.43)   1.54 ( 1.33, 1.78)  
  Private 0.78 ( 0.71, 0.86) <0.0001 0.88 ( 0.77, 1.01)  1.3 ( 1.11, 1.51) <0.0001 1.46 ( 1.24, 1.72)  
Numbers in bold represent statistically significant adjusted risk or protective factors for transfusion. Chronic conditions included chronic hypertension, pre-
existing diabetes, renal disease, cardiac disease. 
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Figure 1: Trends in postpartum haemorrhage, adverse maternal outcomes (MMOI) and red cell 
transfusion rates among vaginal births in NSW, 2003-2011. 
 
Figure 2: Trends in postpartum haemorrhage, adverse maternal outcomes (MMOI) and red cell 
transfusion rates among caesarean section births in NSW, 2003-2011. 
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